SCHEMBL6202837

SCHEMBL6202837

CCOc1ccc(-c2nc(-c3ccc(Cl)cc3)cs2)cc1OCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF2 Q12772 2/20 0.60
KDM4E B2RXH2 5/20 0.59
LMNA P02545 3/20 0.59
MAPT P10636 2/20 0.59
ATM Q13315 1/20 0.59
PDE4A P27815 1/20 0.58
PDE4B Q07343 1/20 0.58
PDE4C Q08493 1/20 0.58
PDE4D Q08499 1/20 0.58
ALDH1A1 P00352 2/20 0.56
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ATP4A P20648 1/20 0.52
ATP4B P51164 1/20 0.52
CYP19A1 P11511 2/20 0.51
CDC25A P30304 1/20 0.50
CDC25B P30305 1/20 0.50
CDC25C P30307 1/20 0.50
DUSP3 P51452 1/20 0.50
SREBF1 P36956 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6194685 0.88 PDE4A (0.66) SREBF2KDM4EMAPTPDE4APDE4B
SCHEMBL6199824 0.87 PDE4A (0.61) SREBF2KDM4ELMNAMAPTATM
Hydrochloric Acid SCHEMBL6199487 0.86 SREBF2 (0.59) SREBF2KDM4EMAPTPDE4APDE4B
SCHEMBL7499486 0.84 PDE4A (0.58) SREBF2KDM4EMAPTATMPDE4A
Iodide SCHEMBL6202003 0.84 PDE4A (0.55) SREBF2KDM4ELMNAMAPTATM
SCHEMBL7499471 0.84 PDE4A (0.55) SREBF2KDM4EMAPTATMPDE4A
SCHEMBL6199960 0.84 PDE4A (0.55) SREBF2KDM4EMAPTPDE4APDE4B
SCHEMBL6201319 0.83 PDE4A (0.60) SREBF2KDM4EMAPTATMPDE4A
SCHEMBL4279626 0.82 ALOX5 (0.64) SREBF2KDM4ELMNAMAPTATM
SCHEMBL11455238 0.82 KDM4E (0.63) SREBF2KDM4EMAPTATMPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed